RANI
Rani Therapeutics Holdings IncKey Statistics
About Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings Inc. is a pioneering biotechnology firm that revolutionizes injectable therapeutic delivery through its proprietary RaniPill™ technology, enabling the oral administration of biologics. This innovative platform not only enhances patient adherence but also improves treatment outcomes, effectively addressing critical gaps in the healthcare landscape. With a diverse pipeline targeting various therapeutic areas, Rani Therapeutics is well-positioned to disrupt conventional drug delivery methods while leveraging the increasing demand for non-invasive treatment solutions. Furthermore, the company's strategic collaborations and strong emphasis on research and development highlight its potential for substantial growth and meaningful contributions to the pharmaceutical sector.
Fundamentals
| Revenue (TTM) | $1.63M |
| Gross Profit (TTM) | $1.63M |
| EBITDA | $-37.41M |
| Operating Margin | -584.00% |
| Return on Equity | -182.00% |
| Return on Assets | -50.30% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $0.34 |
| Price-to-Book | 2.64 |
| Price-to-Sales (TTM) | 66.81 |
| EV/Revenue | 25.59 |
| EV/EBITDA | -1.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 42.10% |
| Shares Outstanding | $99.81M |
| Float | $64.35M |
| % Insiders | 5.60% |
| % Institutions | 49.61% |
Historical Volatility
Volatility is currently contracting